Recent Rates of Systemic Treatment for Metastatic NSCLC in Older Adults - Summary - MDSpire
From the Journals

Recent Rates of Systemic Treatment for Metastatic NSCLC in Older Adults

In a cohort study reported in JAMA Oncology, Fox et al found that approximately half of older patients with metastatic non–small cell lung cancer (NSCLC) have received systemic therapy in the United S...

  • By

  • Matthew Stenger

  • May 12, 2026

  • 3 min

Share

A study published in JAMA Oncology by Fox et al. highlights that about 46.8% of older patients with metastatic non–small cell lung cancer (NSCLC) in the U.S. received systemic therapy from 2006 to 2021. The research involved 254,611 patients aged 65 and older, revealing a notable increase in therapy uptake to 51.6% in 2019 before slightly declining during the COVID-19 pandemic. Factors like oncology specialist referrals and biomarker testing significantly influenced treatment likelihood, suggesting room for improvement in care delivery for this vulnerable population.

Original Source(s)

Recent Rates of Systemic Treatment for Metastatic NSCLC in Older Adults

  • by Matthew Stenger

  • May 12, 2026

Related Content

Flu Hospitalization Tied to Diabetes Risk

A large English cohort study found influenza hospitalization more than doubled the short-term risk of new-onset diabetes, with prediabetes and critical care admission among the strongest predictors.

E-Cigarette Devices Linked to Inhaled Metal Exposure 

Device-to-tissue mass spectrometry traces metal emissions from e-cigarette components into exposed lung sections

  • May 12, 2026

  • 3 min
Stewardship Cuts Steroid Prescribing

Behaviorally informed peer comparison feedback was associated with a gradual decline in glucocorticoid prescribing